Lodonal：Lodonal (naltrexone low dose oral) Biostax Corp

Lodonal (naltrexone low dose oral) Biostax Corp

Theresultssuggestthatlow-dosenaltrexoneisnoteffectiveinmanagingchronicpainandimprovingthequalityoflifeinpatientswithdiversechronicpain ...。其他文章還包含有：「BiostaxEX」、「ImmuneTherapeuticssaysNAFDACapprovesLodonal」、「ImmuneTherapeuticsAnnouncesExclusiveAgreement...」、「imun」、「BiostaxCorp」、「Biostax与Immgenuity签署合作协议，寻求艾滋病毒缓解」、「ImmuneTherapeuticsAnnouncesFilingAcc...

查看更多離開網站

Immune Therapeutics Biostax

Provide From Google

Biostax EX

https://www.biostaxcorp.com

Lodonal is currently approved in Nigeria for the treatment of HIV. The approval is for a one-day Immune System Regulator for the management of HIV/AIDS.

Provide From Google

Immune Therapeutics says NAFDAC approves Lodonal

https://www.reuters.com

NAFDAC approved lodonal as over counter, non-toxic adjunct therapy in treatment of HIV/Aids and immune system regulator Source text for ...

Provide From Google

Immune Therapeutics Announces Exclusive Agreement ...

https://www.biospace.com

Lodonal is an opiate antagonist shown to act as an immune modulator that works by rebalancing and restoring the immune system. Lodonal ...

Provide From Google

imun

https://www.sec.gov

IRT-103 is an active immunotherapy drug consisting of 4.5 mg naltrexone hydrochloride, also referred to as Low Dose Naltrexone (LDN) or LODONAL™ (LODONAL).

Provide From Google

Biostax Corp

https://www.biostaxcorp.com

Lodonal ™. The Once-a-day Immune System-Regulator for the Management of HIV/AIDS. Committed to the Global Promise to End AIDS by 2030 · Discover Lodonal ...

Provide From Google